Notes - Consolidated Statement Of Income

ReproCELL Incorporated - Filing #7328561

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Notes - Consolidated statement of income
Notes - Consolidated statement of income
Notes regarding write-downs of inventories
Write-downs of inventories
6,517,000 JPY
58,669,000 JPY
Major components of selling, general and administrative expenses
Research and development expenses included in general and administrative expenses and manufacturing costs for period
Research and development expenses included in general and administrative expenses and manufacturing costs for period
230,595,000 JPY
384,953,000 JPY
339,474,000 JPY
501,508,000 JPY
Notes regarding impairment losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.